Normative data for the EORTC QLQ-C30 from the Austrian general population
Authors:
- Jens LehmannJLJens Lehmann
- Gregor LieglGLGregor Liegl
- Bernhard HolznerBHBernhard Holzner
- on behalf of the EORTC Quality of Life GroupOGon behalf of the EORTC Quality of Life Group
Open Access
- 12 August 2020
- journal article
- research article
- Published by Springer Nature in Health and Quality of Life Outcomes
- Vol. 18 (1) , 1-9
Abstract
Background: The European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 is a widely used cancer-specific questionnaire assessing 15 domains of health-related quality of life (HRQoL). Our aim was to facilitate the interpretation of scores on this questionnaire by providing Austrian normative data based on a general population sample.Methods: The calculation of normative data was based on the EORTC QLQ-C30 data collected from an Austrian general population sample that was part of an international online panel study on the development of European normative data. Data reported herein were stratified and weighted by age and sex. Normative data were calculated for all 15 HRQoL domains of the EORTC QLQ-C30. For precise predictions of EORTC QLQ-C30 scores, a regression model based on sex, age and the presence of health conditions was built.Results: The Austrian sample comprised 1002 Austrian participants (50.1% female, 51.4% when weighted by age and sex based on United Nation statistics). The mean age was 53.7 years (weighted: 47.7 years) and 53.6% (weighted: 47.4%) reported at least one health condition. Men reported better physical (Cohen’sd = 0.17) and emotional (Cohen’sd = 0.17) functioning as well as less fatigue (Cohen’sd = 0.18) and insomnia (Cohen’sd = 0.25) compared with women. Younger individuals (< 40 years) reported less dyspnea (Cohen’sd = 0.61) and pain (Cohen’sd = 0.51), whereas older individuals (≥60 years) reported better emotional functioning (Cohen’sd = 0.55).Conclusions: We present Austrian normative data for the EORTC QLQ-C30. Differences by age and sex are mostly in line with the findings of other European normative studies. The Austrian population sample shows higher HRQoL and lower morbidity compared with other European countries. The normative data in this study will facilitate the interpretation of EORTC QLQ-C30 scores in oncological practice and research at a national and international level (including cross-cultural comparisons).Keywords
Funding Information
- European Organisation for Research and Treatment of Cancer (001 2015)
This publication has 32 references indexed in Scilit:
- Danish population-based reference data for the EORTC QLQ-C30: associations with gender, age and morbidityQuality of Life Research, 2014
- European reference values for the quality of life questionnaire EORTC QLQ-C30: Results of a German investigation and a summarizing analysis of six European general population normative studiesActa Oncologica, 2014
- Reporting of health-related quality of life (HRQOL) data in oncology trials: a comparison of the European Organization for Research and Treatment of Cancer Quality of Life (EORTC QLQ-C30) and the Functional Assessment of Cancer Therapy-General (FACT-G)Quality of Life Research, 2013
- Health-related quality of life and disease specific symptoms in long-term thyroid cancer survivors: A study from the population-based PROFILES registryActa Oncologica, 2012
- Reference values for the EORTC QLQ-C30 quality of life questionnaire in a random sample of the Swedish populationActa Oncologica, 2011
- Health‐related quality of life among thyroid cancer survivors: a systematic reviewClinical Endocrinology, 2011
- Are gender-associated differences in quality of life in colorectal cancer patients disease-specific?Quality of Life Research, 2009
- Health-Related Quality of Life Measurement in Randomized Clinical Trials in Surgical OncologyJournal of Clinical Oncology, 2006
- Using reference data on quality of life—the importance of adjusting for age and gender, exemplified by the EORTC QLQ-C30 (+3)European Journal of Cancer, 1998
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI: Journal of the National Cancer Institute, 1993